Quarterly report pursuant to Section 13 or 15(d)

Commitments and Contingencies (Details Narrative)

v3.22.2
Commitments and Contingencies (Details Narrative) - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2021
Jun. 30, 2022
Jun. 30, 2021
Onxeo S.A      
Option And License Agreement Description   the option agreement includes clinical, regulatory, developmental and sales milestones that could reach up to $108 million if the Company achieves all milestones, and escalating royalties on net sales from 5% to 10%.  
Patent term   20 years  
One-time license fee   $ 1,000,000  
XOMA Ltd      
Option And License Agreement Description   that could reach up to $14.925 million if the Company achieves all milestones  
GEIS      
Clinical-related Expenses $ 300,000.0   $ 300,000
1000 Skokie Blvd [Member]      
Operating Lease Monthly Payment   $ 4,238  
1,202 square feet [Member]      
Operating Lease Monthly Payment   2,379  
Additional Office Space [Member]      
Operating Lease Monthly Payment   $ 1,859